EVALUATION OF THE VON WILLEBRAND FACTOR (VWF) INHIBITOR IN A LARGE COHORT OF EUROPEAN AND IRANIAN PATIENTS PREVIOUSLY DIAGNOSED WITH TYPE 3 VON WILLEBRAND DISEASE (VWD3) ENROLLED INTO THE 3WINTER-IPS PROJECTL. Baronciani,U. Budde, F. Stufano,F. Peyvandi,A. Goodeve, R. Schneppenheim, Z. Badiee,M. R. Baghaipour, J. Battle,E. Berntorp, I Bodo,G. Castaman,H. C. J. Eikenboom,P. Eshghi, C. Ettorre, J. Goudemand, W. Hassenpflug, C. R. M. Hay, H. Hoorfar,M. Karimi,B. Keikhaei,R. Lassila,F. W. G. Leebeek,M. F. Lopez Fernandez,P. M. Mannucci,M. G. Mazzucconi, M. Morfini, J. Oldenburg, R. Parra Lopez, I. Peake, A. Tiede,G. Toogeh,A. Tosetto, M. Trossaert, S. O. Reza Zekavat, E. M. K. Zetterberg,A. B. FedericiHAEMATOLOGICA（2019）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
